In the original article, there was a mistake in the caption for Figure 6C as published. A clerical error occurred when we prepared the paper. The correct caption appears below.
“(C) Densitometric quantification analysis of the protein expression levels of p-PI3K, PI3K, p-AKT, AKT, p-mTOR, and mTOR in mice.”
In the original article, there was a mistake in Figures 2, 5, 6 as published. The image in the “LPS + Nef” group within Figure 2B, the image in the “LPS + Nef” group within Figure 5A, and the mTOR bands within Figure 6E, were uploaded with errors. The corrected Figures 2, 5, 6 appear below.
FIGURE 2
FIGURE 5
FIGURE 6
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
neferine, apoptosis, oxidative stress, mitochondria, lipopolysaccharide, cardiac dysfunction, sepsis
Citation
Qi Z, Wang R, Liao R, Xue S and Wang Y (2022) Corrigendum: Neferine Ameliorates Sepsis-Induced Myocardial Dysfunction Through Anti-Apoptotic and Antioxidative Effects by Regulating the PI3K/AKT/mTOR Signaling Pathway. Front. Pharmacol. 13:913778. doi: 10.3389/fphar.2022.913778
Received
06 April 2022
Accepted
13 April 2022
Published
29 April 2022
Volume
13 - 2022
Edited and reviewed by
Francesco Rossi, University of Campania Luigi Vanvitelli, Italy
Updates
Copyright
© 2022 Qi, Wang, Liao, Xue and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Song Xue, xuesong64@163.com; Yongyi Wang, wangyongyi@renji.com
†These authors have contributed equally to this work
This article was submitted to Cardiovascular and Smooth Muscle Pharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.